The cost of an individual injection is high, other cost factors substantially contribute to the societal costs of adult-onset dystonias. Some of these costs may be attenuated with the use of Botulinum toxin
2009
Scholarcy highlights
- The cost of an individual injection is high, other cost factors substantially contribute to the societal costs of adult-onset dystonias. Some of these costs may be attenuated with the use of Botulinum toxin
- The subjective and objective relief of these socially devastating and sometimes painful conditions rewards the expenditure associated with the use of BTX serotype A
Need more features? Save interactive summary cards to your Scholarcy Library.